Blue Horseshoe Stocks: DAL Options & More

Delta Airlines Inc. DAL

Despite a tumultuous day for the markets yesterday, and mostly everything taking on a bearish characteristic, we’re still going to go bullish on DAL in the wake of the company’s quarterly earnings report released this morning.

Despite rising fuel costs, the company revealed that profits soared well past expectations as a result of increased demand leading to higher ticket prices.

As we always try to do when a company posts a solid beat, we’ll designate a range of options to place on watch, in this case the DAL Weekly $49.50-52 Calls. We’ll go ahead and track these into the end of the week. DAL stock was already oversold, getting hammered for weeks, so this report may be just the catalyst needed to effect an impressive reversal.



SPDR S&P 500 ETF (SPY)

We had great success with the SPY earlier this week, and we want to come back to it this morning in the wake of the markets getting crushed yesterday. With the amount of uncertainty and potential volatility out there, we want to set ourselves up to have an active idea no matter which way the winds blow.

Should the SPY fall below $276, we will target the SPY Weekly $277 & $276 Puts. If it pulls above $276 we will focus on the $276 and $277 Calls, so either way, we should be able to quickly identify the proper course once trading commences. .


Extended Watchlist: 
SBGL, PRPO, RH, HEAR, CEI, HMY, ACST, HSGX

Blue Horseshoe Stocks: SPY Puts Recap & More

SPDR S&P 500 ETF (SPY) – Review

We went bearish on the SPY yesterday morning, and offered up a set of corresponding ideas in the options chain. We signaled our interest in the SPY 10/08 $288.50-$287.50 Puts which just had the one session before expiration.

It turned out to be a great rapid-strike play for anyone who cared to take advantage. Every single contract in our designated group produced legitimately impressive multi-bag intraday gain opportunities.

$288.50 Puts – Range: .71-2.90 – Max Gain: 308%
$288 Puts – Range: .47-2.50 – Max Gain: 432%
$287.50 Puts – Range: .31-2.00 – Max Gain: 545%


Kala Pharmaceuticals, Inc. KALA

Catching our eye as a potential bottom bounce play this morning is KALA, which is presently exhibiting all of the bottom play indicators we typically look for. The RSI is in indicating that the stock is oversold, but with strength rising, and the MACD is sharply converging toward an impending cross.

Meanwhile the PPS showed its first inclination yesterday of attempting to fill in the topside gap we can also plainly see on the snapshot below. We’re going yto place the stock on watch for a continued rebound, and also tag the KALA 01/18 $10 & 12.50 Calls for observation in the days and weeks ahead.





CorMedix, Inc. CRMD

We placed CRMD on watch beginning on last Monday, October 1st, and subsequent to that report, would observe a low of 1.06 in the stock. Yesterday, CRMD attained a new high of 1.65, marking a notable 56% upswing in just a weeks time.


Extended Watchlist: 
CZNI, AGRX, OGEN, MOSY, HELE, PYX, DGLY

Blue Horseshoe Stocks: Bottom-Watch Play & More

Aytu Bioscience, Inc. AYTU

We’re always on the lookout for a bargain, and we may have a prime bottom play opportunity in AYTU in the near future. The stock has been on the downtrend for a couple of months, and is presently very heavily oversold.

We’re going to put this play on our radar and watch carefully for a bottom-bounce which appears to be imminent. Gaining back even half of the ground its recently lost would mean more than a dounble from the current PPS.


SPDR S&P 500 ETF (SPY)

We’re also looking at the SPY today after a lackluster finish to last week. Market sentiment still appears to be bearish as we ready ourselves to kick off this fresh trading week.

We are going to be tracking a set of bearish options, particularly the SPY 10/08 $288.50-$287.50 Puts. Keep in mind that these expire at the end of the day, thus should be treated as weekly options on a Friday. Only expert traders with disposable income should attempt these kinds of trades.


Extended Watchlist: 
BBD, CIG, CRMD, RGSE, MOSY, PAGS, JAGX, ATIS

Blue Horseshoe Stocks: New Highs Everywhere!

New Highs Everywhere!

We were just updating readers on the progress of TLRY, DCTH, and NBEV in yesterday morning’s report. We were already impressed with their performances prior to yesterday, and yet each one managed to pile on the potential gains. All three rose sharply to new highs, so we’re coming right back to recap those excellent moves today. .

Tilray, Inc. TLRY – This is the hottest new IPO, and we’ve been tracking it since last Tuesday, at which time the stock was trading at 87.50. Yesterday it hit $300 even, an incredible seven-day swing of 243%

We were also tracking the TLRY 09/21 $91-93 Calls, which made great moves but have since been pushed so far into the money that they’ve been passed over, with the exception of the $93’s, which were still trading volume yesterday, and reached a high of 139.24, From our observed low of 5.23, that marks a fantastic gain of 2562%
_____

Delcath Systems, Inc. DCTH –
This play was placed on our watchlist three weeks ago on August 28th while trading as low as 1.76. Yesterday, it made its biggest single session move yet, rocketing to 10.30, for a huge rise of 485%
______

New Age Beverage Holdings, Inc. NBEV – Lastly, NBEV also logged its biggest single-day performance of all-time yesterday, as the stock ran to a new high of 4.94. We’ve been mentioning it frequently since the 4th of this month, as it was trading for as little as 1.50. We’ve thus far witnessed a 229% run in NBEV, who will be rolling out a CBD beverage line at an upcoming conference early next month. 
______

Greater Cannabis Co Inc. GCAN
Off of our cannabis watchlist yesterday came GCAN, which ran hard from .1453-.735, for an eye-popping single session gain of 406%
______

Fresh Options Idea:
Darden Restaurants Inc. DRI  Weekly $120 & $125 Calls
SPDR S&P 500 ETF (SPY) Weekly $291.50-292.50


Extended Watchlist:
NIHD, FNJN, LCI, TNDM, NEPT, GALT

Blue Horseshoe Stocks: Form-4 Plays & More

SPDRA S&P 500 ETF (SPY) – Recap

Our first order of business this morning is to share the performance of the options we alerted on in Friday morning’s report. Those targets were the SPY Weekly $290-291.50 Calls, and they produced some very nice single session gain opportunities for ourselves and our readers.

We have typically been very good playing the SPY in the past, and this time was no different, The gains that were on the table were as follows:

$290 Calls – Range: .34-1.04 – Max Gain: 206%
$290.50 Calls – Range: .12-.58 – Max Gain: 383%
$291 Calls – Range: .20-.46 – Max Gain: 130%
$291.50 Calls – Range: .08-.19 – Max Gain: 138%



Francesca Holdings Corp. FRAN
& Amicus Therapeutics, Inc. FOLD

This morning we noticed that FRAN is exhibiting a number of traits that we normally keep a lookout for. The stock is coming off of a bottom with a large gap on the chart, and on Friday, the CEO filed a Form-4 for the purchase of 10,000 shares near the stock’s lows.

This is often a sign of high internal confidence in the stock’s ability to rebound, so we’re going to place FRAN on recovery watch in the days and weeks ahead.
_____

FOLD is another play which also currently boasts a bottom setup, with a significant amount of insider buying taking place on Thursday at its lows. We’ll definitely want to keep this one on watch as well.


Extended Watchlist:
ACBFF, TLRY, CGC, TPIV, SNES, NSPR

Get Our FREE Daily Reports!